Basic Information
CoreMedic Develops and Manufactures Devices and Therapies for Treating Heart Valve DiseasesCoreMedic's flagship product, ChordArt, is a trans-femoral system designed to repair the mitral valve and chords in a beating heart. ChordArt™ offers a first-line treatment option for patients with mitral valve dysfunction, representing a less invasive alternative compared to current surgical approaches that utilize open-chest or trans-apical access. ChordArt aims to enable mitral valve repair in a broader patient population. ChordArt™ is currently undergoing clinical evaluation in European clinics. CoreMedic is a private medical device company headquartered in Radolfzell, Germany, with a subsidiary in Biel/Bienne, Switzerland.
CoreMedic AG
Germany
less than 15 people
June 01, 2012
info@coremedic.de
